Table 1.
Clinicopathological data of vitiligo patients
| Characteristic | No. (%) |
|---|---|
| Age (yr) | |
| Mean ± SD | 34.95 ± 15.05 |
| Median (range) | 27.00 (18–64) |
| Disease duration (yr) | |
| Mean ± SD | 5.13 ± 3.62 |
| Median (range) | 4.00 (2–15) |
| Sex | |
| Male | 16 (41) |
| Female | 23 (59) |
| Onset (yr) | |
| < 20 | 10 (25.6) |
| ≥ 20 | 29 (74.4) |
| Family history | |
| Negative | 26 (66.7) |
| Positive | 13 (33.3) |
| Type | |
| Acral | 10 (25.6) |
| Acrofacial | 6 (15.4) |
| Focal | 3 (7.7) |
| Generalized | 3 (7.7) |
| Segmental | 4 (10.3) |
| Vulgaris | 13 (33.3) |
| Distribution | |
| NSV | 13 (33.3) |
| SV | 26 (66.7) |
| Melanin | |
| Absent | 22 (56.4) |
| Present | 17 (43.6) |
| Dermal inflammation | |
| Mild | 26 (66.7) |
| Moderate | 13 (33.3) |
| HMB45 status | |
| Negative | 16 (41.0) |
| Positive | 23 (59.0) |
| HMB-45 (%) | |
| Mean ± SD | 18.17 ± 27.99 |
| Median (range) | 1.00 (0–90) |
SD, standard deviation; NSV, non-segmental vitiligo; SV, segmental vitiligo; HMB45, human melanoma black 45.